Pharmaceutical

Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine

Novavax has sought EMA approval for its updated JN.1 Covid-19 vaccine, NVX-CoV2705, for people aged 12 years and above.

Jun 26, 2024 - 04:00
Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine
Novavax has sought EMA approval for its updated JN.1 Covid-19 vaccine, NVX-CoV2705, for people aged 12 years and above.
Read the original article

Tags:

Previous Article

Oncoinvent’s Radspherin has FDA fast-track status for ovarian cancer

Next Article

GSK’s Omjjara gains approval in Japan for myelofibrosis treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Morning Rounds: Teen pregnancies down, but remain higher in the U.S. 

Morning Rounds: Teen pregnancies down, but remain highe...

Dec 15, 2023

STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more

STAT+: Pharmalittle: We’re reading about a nixed Medica...

Mar 4, 2024

What explains rare heart condition among young men after Covid vaccines? A new study offers clues

What explains rare heart condition among young men afte...

May 5, 2023